García Mónica, Morán Asunción, Luisa Martín María, Barthelmebs Mariette, San Román Luis
Laboratorio de Farmacognosia y Farmacología, Departamento de Fisiología y Farmacología, Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, ES-37007 Salamanca, Spain.
Eur J Pharmacol. 2006 May 10;537(1-3):126-34. doi: 10.1016/j.ejphar.2006.03.020. Epub 2006 Mar 20.
We investigated the involvement of the nitric oxide pathway in the inhibitory mechanisms of 5-hydroxytryptamine (5-HT) in the pressor responses induced by stimulation of sympathetic vasopressor outflow in diabetic pithed rats. Diabetes was induced in male Wistar rats by a single s.c. injection of alloxan. Four weeks later, the animals were anaesthetized, pretreated with atropine, and pithed. Electrical stimulation of the sympathetic outflow from the spinal cord (0.1, 0.5, 1 and 5 Hz) resulted in frequency-dependent increases in blood pressure. The inhibition of electrically induced pressor responses by 5-HT (10 microg/kg/min) in diabetic pithed rats could not be elicited after i.v. treatment with 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) (10 microg/kg), a guanylyl cyclase inhibitor, or N-omega-L-Arginine methyl ester hydrochloride (L-NAME) (10 mg/kg), a nitric oxide synthase (NOS) inhibitor. The inhibitory effect produced by infusion of the selective 5-HT(1A) receptor agonist 8-hydroxydipropylaminotretalin hydrobromide (8-OH-DPAT) (20 microg/kg/min) was abolished in the presence of ODQ (10 microg/kg), or L-NAME (10 mg/kg) in diabetic pithed rats. The administration of L-Arginine (100 mg/kg) 30 min after L-NAME reproduced the inhibitory effect caused by 5-HT (10 microg/kg/min) and 8-OH-DPAT (20 microg/kg/min) on the electrically induced pressor responses, whereas in the presence of D-Arginine (100 mg/kg)+L-NAME the 5-HT or 8-OH-DPAT inhibitory effect on the pressor responses was abolished. In conclusion, in diabetic pithed rats, the inhibition produced by prejunctional 5-HT(1A) activation on electrically induced sympathetic pressor responses is mediated by the NO synthesis/pathway.
我们研究了一氧化氮途径在5-羟色胺(5-HT)对糖尿病去脑大鼠交感缩血管传出神经刺激诱导的升压反应抑制机制中的作用。通过单次皮下注射四氧嘧啶诱导雄性Wistar大鼠患糖尿病。四周后,将动物麻醉,用阿托品预处理,然后去脑。对脊髓交感传出神经进行电刺激(0.1、0.5、1和5Hz)导致血压随频率依赖性升高。在用鸟苷酸环化酶抑制剂1H-[1,2,4]恶二唑并[4,3-a]喹喔啉-1-酮(ODQ)(10μg/kg)或一氧化氮合酶(NOS)抑制剂N-ω-L-精氨酸甲酯盐酸盐(L-NAME)(10mg/kg)静脉注射治疗后,糖尿病去脑大鼠中5-HT(10μg/kg/min)对电诱导升压反应的抑制作用无法引出。在糖尿病去脑大鼠中,当存在ODQ(10μg/kg)或L-NAME(10mg/kg)时,选择性5-HT(1A)受体激动剂8-羟基二丙基氨基四氢萘氢溴酸盐(8-OH-DPAT)(20μg/kg/min)输注产生的抑制作用被消除。在L-NAME给药30分钟后给予L-精氨酸(100mg/kg)可重现5-HT(10μg/kg/min)和8-OH-DPAT(20μg/kg/min)对电诱导升压反应的抑制作用,而在存在D-精氨酸(100mg/kg)+L-NAME的情况下,5-HT或8-OH-DPAT对升压反应的抑制作用被消除。总之,在糖尿病去脑大鼠中,节前5-HT(1A)激活对电诱导交感升压反应产生的抑制作用是由NO合成/途径介导的。